Director/PDMR Shareholding

Arix Bioscience Plc

31 May 2023

 

Arix Bioscience plc
(the "Company")

PDMR notification & Director Shareholding

The Company today announces it has granted an executive award of nil cost options (the "Award") under the Arix Bioscience plc Executive Incentive Plan (the "Plan") to CEO Robert Lyne, which are subject to performance conditions over a three-year period from 1 January 2023 to 31 December 2025 (the "Performance Period"). The Award takes the form of an option to acquire up to 671,800 ordinary shares of £0.00001 each in the Company. Vested Shares are subject to a further two-year holding period, as set out in the Plan. The performance conditions attached to the Award are set out in the Director's Remuneration Report on page 55 of Company's Annual Report & Accounts 2022.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Lyne
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP")
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			Nil	671,800
d)	Aggregated information
	- Aggregated volume	N/A (Single Transaction)
	- Price	N/A (Single Transaction)
e)	Date of the transaction	30 May 2023
f)	Place of the transaction	Outside a trading venue

For further information please contact:
Kin Company Secretarial Limited, Company Secretary
[phone]

 

END